10-K: FitLife Brands Reports Strong Revenue Growth in 2023 Following Strategic Acquisitions

FitLife Brands, Inc. saw an 83% increase in revenue in 2023, driven by the acquisitions of Mimis Rock Corp and MusclePharm assets.

Summary

• FitLife Brands, Inc. reported an 83% increase in revenue for the year ended December 31, 2023, reaching $52.7 million, compared to $28.8 million in 2022.
• The revenue growth was primarily due to the acquisition of Mimis Rock Corp (MRC) in February 2023.
• Legacy FitLife revenue decreased by 3%, with a 9% decline in wholesale revenue partially offset by a 14% increase in online revenue.
• The acquisition of MusclePharm assets in October 2023 had a minimal impact on 2023 revenue due to the timing of the transaction and the need to procure inventory.
• Online revenue accounted for approximately 63% of total revenue in 2023, compared to 28% in 2022.
• Gross profit increased by 78% to $21.4 million in 2023, compared to $12 million in 2022.
• Net income for 2023 was $5.3 million, a 20% increase compared to $4.4 million in 2022.
• The company's gross margin decreased slightly to 40.7% in 2023 from 41.8% in 2022, primarily due to the amortization of the fair value step-up to MRC inventory and inflationary pressures.
• Selling, general, and administrative expenses increased to $12.2 million in 2023 from $6 million in 2022, mainly due to the inclusion of MRC's expenses.
• Merger and acquisition-related expenses increased to $1.6 million in 2023, driven by costs related to the MRC acquisition.
• The company had a positive working capital of $4.4 million as of December 31, 2023, compared to $18.9 million at the end of 2022.
• The decrease in working capital was primarily due to the acquisitions of MRC and MusclePharm assets.
• The company has $20.1 million outstanding on term loans as of December 31, 2023.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong revenue growth and strategic acquisitions. However, there are some risks and challenges that need to be monitored, such as the reliance on GNC and the decrease in working capital. Overall, the sentiment is positive but with some caution.

Positives

• The company experienced substantial revenue growth, driven by strategic acquisitions.
• Online sales have become a major revenue driver, indicating a successful shift in sales strategy.
• The company achieved a significant increase in net income, demonstrating improved profitability.
• The company successfully acquired both MRC and MusclePharm assets, expanding its product portfolio and market reach.
• The company is in compliance with all covenants of its credit agreement as of December 31, 2023.

Negatives

• Legacy FitLife revenue decreased by 3%, indicating challenges in the core business.
• Gross margin decreased slightly due to acquisition-related costs and inflationary pressures.
• Working capital decreased significantly due to the cash used for acquisitions.
• The acquisition of MusclePharm had a minimal impact on revenue in 2023 due to the timing of the transaction and the need to procure inventory.
• The company is dependent on a limited number of suppliers and manufacturers.

Risks

• The company is dependent on sales to GNC for a substantial portion of its total sales, and any reduction in GNC purchases could negatively impact revenue.
• The company relies on a limited number of third-party suppliers and manufacturers, which could affect its ability to deliver products in a timely manner.
• The company faces significant competition in the nutrition industry, which could impact its ability to maintain profitability.
• Adverse publicity associated with the company's products or ingredients could negatively affect sales and revenue.
• The company is exposed to product liability risks, which could result in significant insurance and loss expenses.
• The company may experience difficulties in integrating the operations of MRC and MusclePharm into its business.
• The company's stock price could be subject to wide fluctuations, and the company may not be able to sustain profitability.
• The company is subject to extensive laws and regulations, and failure to comply could lead to enforcement actions and penalties.
• The company is dependent on key personnel, and the loss of these individuals could impair its ability to operate.
• The company's ability to materially increase sales is largely dependent on the ability to increase sales of product to its wholesale partners as well as directly to the end consumer.

Future Outlook

The company anticipates that cash derived from operations and existing cash resources, along with available borrowings under the Line of Credit, will be sufficient to provide for the company's liquidity for the next twelve months. Management believes that online revenue will continue to increase in subsequent periods given the focus on higher margin online sales and the acquisitions of MRC and MusclePharm.

Management Comments

• Management is committed to continue to work collaboratively with GNC and its franchisees to build on our established track record of innovation and operational performance.
• Management also believes that its focus on developing its e-commerce capabilities will drive additional incremental sales in the short-term, while yielding substantial benefits in the longer-term.

Industry Context

The company competes in the highly competitive nutrition industry, which is driven by factors such as increased awareness of the connection between diet and health, an aging population, increasing healthcare costs, and product introductions based on new scientific studies. The company's acquisitions and focus on online sales align with broader industry trends.

Comparison to Industry Standards

• The company's 83% revenue growth significantly exceeds the average growth rate in the nutrition industry, which has been growing at a strong pace over the past ten years.
• The shift to online sales, now representing 63% of total revenue, is in line with the broader trend of e-commerce growth in the consumer goods sector.
• The company's gross margin of 40.7% is within the typical range for companies in the nutritional supplement industry, although it experienced a slight decrease due to acquisition-related costs and inflationary pressures.
• The company's net income growth of 20% is a positive sign, but it is important to compare this to the performance of similar companies in the sector to assess its relative strength.
• The company's reliance on GNC for a significant portion of its sales is a common practice in the industry, but it also presents a risk if GNC's performance declines or if the relationship is disrupted.
• The company's acquisitions of MRC and MusclePharm are strategic moves to expand its product portfolio and market reach, which is a common strategy among companies in the nutrition industry to gain a competitive edge.
• The company's debt levels, with $20.1 million outstanding on term loans, should be monitored in comparison to industry benchmarks to ensure financial stability.

Stakeholder Impact

• Shareholders will benefit from the increased revenue and profitability.
• Employees may see opportunities for growth and development within the expanded company.
• Customers will have access to a wider range of products and brands.
• Suppliers may see increased demand for their products.
• Creditors will be interested in the company's ability to repay its debts.

Next Steps

• The company will continue to focus on increasing online sales and integrating the acquired businesses.
• The company will continue to work with GNC to expand its product distribution.
• The company will monitor its debt levels and financial performance to ensure continued growth and stability.

Key Dates

Keywords

nutritional supplements, wellness products, acquisitions, Mimis Rock Corp, MusclePharm, online sales, GNC, revenue growth, profitability, financial results